LTF and inflammatory bowel disease: Biomarkers such as CRP, fecal calprotectin, and fecal lactoferrin have been reported to act as surrogate markers of mucosal inflammation in patients with inflammatory bowel disease [23-25], with CRP being a particularly sensitive marker in UC patients.